{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T11:44:58Z","timestamp":1777117498913,"version":"3.51.4"},"reference-count":68,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jaip.2025.06.028","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T03:46:13Z","timestamp":1751427973000},"page":"2674-2685.e12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Step Down From Scheduled Inhaled Corticosteroids (ICS) Plus As-Needed Fast-Acting Beta-Agonists (FABA) to As-Needed ICS\/FABA: A Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8593-4504","authenticated-orcid":false,"given":"Ricardo J.","family":"Estrada-Mendizabal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John B.","family":"Hagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Wonnaparhown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine M.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina G.","family":"Kwong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald W.","family":"Volcheck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa A.","family":"Marks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek K.","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew A.","family":"Rank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2025.06.028_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00281-020-00785-1","article-title":"Asthma epidemiology and risk factors","volume":"42","author":"Stern","year":"2020","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.jaip.2025.06.028_bib3","series-title":"Data, statistics, and surveillance","year":"2021"},{"key":"10.1016\/j.jaip.2025.06.028_bib4","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0140-6736(22)02125-0","article-title":"Asthma","volume":"401","author":"Porsbjerg","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2025.06.028_bib5","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1513\/AnnalsATS.201703-259OC","article-title":"The economic burden of asthma in the United States, 2008-2013","volume":"15","author":"Nurmagambetov","year":"2018","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jaip.2025.06.028_bib6","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1164\/rccm.202304-0642ST","article-title":"Questions in mild asthma: an official American Thoracic Society research statement","volume":"207","author":"Mohan","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2025.06.028_bib7","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0140-6736(00)03611-4","article-title":"Comparison of formoterol and terbutaline for as-needed treatment of asthma: a randomised trial","volume":"357","author":"Tattersfield","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2025.06.028_bib8","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1183\/09031936.03.00055803","article-title":"Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial","volume":"22","author":"Pauwels","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.06.028_bib9","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0140-6736(06)69284-2","article-title":"Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study","volume":"368","author":"Rabe","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2025.06.028_bib10","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1056\/NEJMoa063861","article-title":"Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma","volume":"356","author":"Papi","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2025.06.028_bib11","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1183\/09031936.06.00128005","article-title":"Formoterol as needed with or without budesonide in patients with intermittent asthma and raised NO levels in exhaled air: a SOMA study","volume":"28","author":"Haahtela","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.06.028_bib12","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1056\/NEJMoa1715274","article-title":"Inhaled combined budesonide-formoterol as needed in mild asthma","volume":"378","author":"O\u2019Byrne","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2025.06.028_bib13","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1056\/NEJMoa1715275","article-title":"As-needed budesonide-formoterol versus maintenance budesonide in mild asthma","volume":"378","author":"Bateman","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2025.06.028_bib14","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.5415\/apallergy.2021.11.e9","article-title":"Stepping down therapy for well-controlled mild asthma: an experience from University Medical Center at Ho Chi Minh City","volume":"11","author":"Lam","year":"2021","journal-title":"Asia Pac Allergy"},{"key":"10.1016\/j.jaip.2025.06.028_bib15","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.rmed.2013.05.005","article-title":"Daily vs. intermittent inhaled corticosteroids for recurrent wheezing and mild persistent asthma: a systematic review with meta-analysis","volume":"107","author":"Rodrigo","year":"2013","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2025.06.028_bib16","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0140-6736(10)62145-9","article-title":"Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial","volume":"377","author":"Martinez","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2025.06.028_bib17","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jaip.2019.06.030","article-title":"A pragmatic trial of symptom-based inhaled corticosteroid use in African-American children with mild asthma","volume":"8","author":"Sumino","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.06.028_bib18","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.jaci.2016.09.028","article-title":"Individualized therapy for persistent asthma in young children","volume":"138","author":"Fitzpatrick","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.06.028_bib19","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1001\/2012.jama.10893","article-title":"Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of inhaled corticosteroid therapy in adults with asthma: the BASALT randomized controlled trial","volume":"308","author":"Calhoun","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2025.06.028_bib20","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S2213-2600(14)70266-8","article-title":"Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial","volume":"3","author":"Papi","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2025.06.028_bib21","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(19)31948-8","article-title":"Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial","volume":"394","author":"Hardy","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2025.06.028_bib22","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jaip.2017.07.030","article-title":"Step-down therapy for asthma well controlled on inhaled corticosteroid and long-acting beta-agonist: a randomized clinical trial","volume":"6","author":"Rogers","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.06.028_bib23","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jaci.2003.10.011","article-title":"Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies","volume":"113","author":"Stoloff","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.06.028_bib24","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.jaci.2015.08.035","article-title":"Comparative safety and costs of stepping down asthma medications in patients with controlled asthma","volume":"137","author":"Rank","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.06.028_bib25","doi-asserted-by":"crossref","first-page":"262","DOI":"10.2500\/aap.2015.36.3850","article-title":"Stepping down inhaled corticosteroids from scheduled to as needed in stable asthma: systematic review and meta-analysis","volume":"36","author":"Gionfriddo","year":"2015","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2025.06.028_bib26","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2023"},{"key":"10.1016\/j.jaip.2025.06.028_bib27","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jclinepi.2019.10.014","article-title":"GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions","volume":"119","author":"Santesso","year":"2020","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jaip.2025.06.028_bib28","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2021.03.026","article-title":"GRADE guidelines 32: GRADE offers guidance on choosing targets of GRADE certainty of evidence ratings","volume":"137","author":"Zeng","year":"2021","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jaip.2025.06.028_bib29","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.jaip.2025.06.028_bib30","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1016\/j.jaip.2021.09.035","article-title":"Translating evidence to optimize patient care using GRADE","volume":"9","author":"Chu","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.06.028_bib31","series-title":"GRADE Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach","author":"Sch\u00fcnemann","year":"2013"},{"key":"10.1016\/j.jaip.2025.06.028_bib32","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1034\/j.1399-3003.1999.14d29.x","article-title":"Development and validation of a questionnaire to measure asthma control","volume":"14","author":"Juniper","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.06.028_bib33","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1378\/chest.115.5.1265","article-title":"Validation of a standardized version of the Asthma Quality of Life Questionnaire","volume":"115","author":"Juniper","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2025.06.028_bib34","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJMoa1203229","article-title":"Effect of inhaled glucocorticoids in childhood on adult height","volume":"367","author":"Kelly","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2025.06.028_bib35","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/s41591-022-01714-5","article-title":"Metabolomic profiling reveals extensive adrenal suppression due to inhaled corticosteroid therapy in asthma","volume":"28","author":"Kachroo","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.jaip.2025.06.028_bib36","series-title":"RA Language and Environment for Statistical Computing","author":"Team","year":"2020"},{"key":"10.1016\/j.jaip.2025.06.028_bib37","author":"Team"},{"key":"10.1016\/j.jaip.2025.06.028_bib38","first-page":"153","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"BMJ Ment Health"},{"key":"10.1016\/j.jaip.2025.06.028_bib39","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/all.12368","article-title":"The risk of asthma exacerbation after reducing inhaled corticosteroids: a systematic review and meta-analysis of randomized controlled trials","volume":"69","author":"Hagan","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.06.028_bib40","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1001\/archinternmed.2012.3250","article-title":"Long-acting \u03b22-agonist step-off in patients with controlled asthma","volume":"172","author":"Brozek","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaip.2025.06.028_bib41","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jaci.2012.11.038","article-title":"The risk of asthma exacerbation after stopping low-dose inhaled corticosteroids: a systematic review and meta-analysis of randomized controlled trials","volume":"131","author":"Rank","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.06.028_bib42","article-title":"Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults","author":"Chauhan","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaip.2025.06.028_bib43","first-page":"Cd009471","article-title":"Inhaled corticosteroids in children with persistent asthma: effects on growth","volume":"2014","author":"Zhang","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaip.2025.06.028_bib44","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1001\/jama.2024.22700","article-title":"Inhaled reliever therapies for asthma: a systematic review and meta-analysis","volume":"333","author":"Rayner","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2025.06.028_bib45","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2500\/aap.2015.36.3839","article-title":"Stepping down from inhaled corticosteroids with leukotriene inhibitors in asthma: a systematic review and meta-analysis","volume":"36","author":"Rank","year":"2015","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2025.06.028_bib46","doi-asserted-by":"crossref","first-page":"00701","DOI":"10.1183\/23120541.00701-2020","article-title":"ICS-formoterol reliever versus ICS and short-acting \u03b2(2)-agonist reliever in asthma: a systematic review and meta-analysis","volume":"7","author":"Hatter","year":"2021","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jaip.2025.06.028_bib47","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.0615","article-title":"Evaluation of budesonide-formoterol for maintenance and reliever therapy among patients with poorly controlled asthma: a systematic review and meta-analysis","volume":"5","author":"Beasley","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jaip.2025.06.028_bib48","article-title":"Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma","volume":"5","author":"Crossingham","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaip.2025.06.028_bib49","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.jaci.2020.10.003","article-title":"2020 Focused Updates to the Asthma Management Guidelines: a report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group","volume":"146","author":"Cloutier","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.06.028_bib50","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1034\/j.1399-3003.1999.14d29.x","article-title":"Development and validation of a questionnaire to measure asthma control","volume":"14","author":"Juniper","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.06.028_bib51","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1378\/chest.115.5.1265","article-title":"Validation of a standardized version of the Asthma Quality of Life Questionnaire","volume":"115","author":"Juniper","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2025.06.028_bib52","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaci.2003.09.008","article-title":"Development of the asthma control test: a survey for assessing asthma control","volume":"113","author":"Nathan","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.06.028_bib54","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0137-2019","article-title":"Minimal clinically important difference for asthma endpoints: an expert consensus report","volume":"29","author":"Bonini","year":"2020","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.jaip.2025.06.028_bib55","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jaci.2009.06.053","article-title":"The minimally important difference of the Asthma Control Test","volume":"124","author":"Schatz","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.06.028_bib56","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-3438","article-title":"Clinical tools to assess asthma control in children","volume":"139","author":"Dinakar","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaip.2025.06.028_bib57","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1034\/j.1399-3003.1999.14a08.x","article-title":"Development and validation of the Mini Asthma Quality of Life Questionnaire","volume":"14","author":"Juniper","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.06.028_bib58","series-title":"Pulmonary Function Tests. Treasure Island, FL: StatPearls Publishing","author":"Ponce","year":"2025"},{"key":"10.1016\/j.jaip.2025.06.028_bib59","article-title":"ERS\/ATS technical standard on interpretive strategies for routine lung function tests","volume":"60","author":"Stanojevic","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.06.028_bib60","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1136\/bmj.317.7164.986","article-title":"Comparison of potency of inhaled beclomethasone and budesonide in New Zealand: retrospective study of computerised general practice records","volume":"317","author":"Pethica","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.jaip.2025.06.028_bib61","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jclinepi.2019.10.014","article-title":"GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions","volume":"119","author":"Santesso","year":"2020","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jaip.2025.06.028_bib62","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1016\/j.jaip.2021.09.035","article-title":"Translating evidence to optimize patient care using GRADE","volume":"9","author":"Chu","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.06.028_bib63","series-title":"GRADE Handbook for Grading the Quality of Evidence and the Strength of Recommendations Using the GRADE Approach","author":"Sch\u00fcnemann","year":"2013"},{"key":"10.1016\/j.jaip.2025.06.028_bib64","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jaip.2019.06.030","article-title":"A pragmatic trial of symptom-based inhaled corticosteroid use in African-American children with mild asthma","volume":"8","author":"Sumino","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.06.028_bib65","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(19)31948-8","article-title":"Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial","volume":"394","author":"Hardy","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2025.06.028_bib66","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.jaci.2016.09.028","article-title":"Individualized therapy for persistent asthma in young children","volume":"138","author":"Fitzpatrick","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.06.028_bib67","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S2213-2600(14)70266-8","article-title":"Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial","volume":"3","author":"Papi","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2025.06.028_bib68","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1001\/2012.jama.10893","article-title":"Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of inhaled corticosteroid therapy in adults with asthma: the BASALT randomized controlled trial","volume":"308","author":"Calhoun","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2025.06.028_bib69","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0140-6736(10)62145-9","article-title":"Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial","volume":"377","author":"Martinez","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2025.06.028_bib70","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1056\/NEJMoa063861","article-title":"Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma","volume":"356","author":"Papi","year":"2007","journal-title":"N Engl J Med"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219825006099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219825006099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T11:23:30Z","timestamp":1777116210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219825006099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":68,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2213219825006099"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2025.06.028","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Step Down From Scheduled Inhaled Corticosteroids (ICS) Plus As-Needed Fast-Acting Beta-Agonists (FABA) to As-Needed ICS\/FABA: A Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2025.06.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}